MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer

• Váldodahkkit: Jing Yao Wang (Dahkki), Nan Zhang (Dahkki), Xiaojie Yang (Dahkki), Danli Gao (Dahkki), Lirong Yin (Dahkki), Shuying Ji (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Bangladesh Pharmacological Society, 2015-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The purpose of this study is to assess whether MHC class I-presented tumor antigen is appraisable for T-cell responses against ovarian cancer. In ovarian cancer cell, human leukocyte antigen A2 (HLA-A2) associated with peptides was used to promote the activation of naive T cells so as to activate an...